# Feasibility of the AccuCinch® System for Left Ventricular Reshaping of the Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve Left Ventricular Function

> **NCT02153892** · NA · COMPLETED · sponsor: **Ancora Heart, Inc.** · enrollment: 2 (actual)

## Conditions studied

- Severe Functional Mitral Regurgitation and Heart Failure

## Interventions

- **DEVICE:** GDS Accucinch System

## Key facts

- **NCT ID:** NCT02153892
- **Lead sponsor:** Ancora Heart, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-10
- **Final completion:** 2018-01
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2018-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02153892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02153892, "Feasibility of the AccuCinch® System for Left Ventricular Reshaping of the Mitral Apparatus to Reduce Functional Mitral Regurgitation and Improve Left Ventricular Function". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02153892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*